Kairos Pharma, Ltd. (KAPA)

Kairos Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021
Market Capitalization	51	-	-
Enterprise Value	51	-	-
Debt / Equity Ratio	-0.39	-0.50	-1.89
Debt / EBITDA Ratio	-1.26	-1.36	-1.17
Debt / FCF Ratio	-3.08	-1.66	-5.35
Quick Ratio	0.12	0.27	0.04
Interest Coverage	-15.24	-19.59	-106.25
Return on Equity (ROE)	52.02%	89.06%	183.80%
Return on Assets (ROA)	-	-101.35%	-276.77%
Return on Capital (ROIC)	67.23%	96.29%	-187.19%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).